TABLE 1.
NK cell content in apheresis products
| Apheresis product source | TNC (×106) | CD45+CD56+CD3- NKs (%) | Absolute number of NKs (×106) |
|---|---|---|---|
| Healthy donor | 6222 | 4 | 249 |
| Healthy donor | 21600 | 4 | 864 |
| Healthy donor | 16328 | 7 | 1143 |
| Healthy donor | 21200 | 10 | 2120 |
| Myeloma patient | 7181 | 17 | 1221 |
| Myeloma patient | 11368 | 13 | 1478 |
| Myeloma patient | 10560 | 16 | 1690 |
| Myeloma patient | 35088 | 10 | 3509 |
| Myeloma patient | 14190 | 36 | 5108 |
| Average±StDev | 15971±9018 | 13±10 | 1931±1499 |